The state of the art of fetal hemoglobin-inducing agents
Sign Up to like & getrecommendations! Published in 2022 at "Expert Opinion on Drug Discovery"
DOI: 10.1080/17460441.2022.2141708
Abstract: ABSTRACT Introduction Sickle cell anemia (SCA) is a hematological genetic disorder caused by a mutation in the gene of the β-globin. Pharmacological treatments will continue to be an important approach, including the strategy to induce… read more here.
Keywords: new drugs; art fetal; hbf; state art ... See more keywords